The Europe Bioinformatics Market should witness market growth of 12.3% CAGR during the forecast period (2022-2028).
Combining molecular and chemical methods, bioinformatics approaches are used in the search for natural compounds. The ability to conduct a large-scale screening and phylogenetic resolution are crucial molecular approach characteristics. Understanding the genetic and epigenetic elements of various bacterial taxa requires the use of comparative genome sequence analysis. The rising number of completely sequenced microbial genomes, such as those from well-known bacterial manufacturers of natural products, has made it obvious that these microbes have significantly greater genomic and metabolic capacities than once thought. This is because 'silent' or 'cryptic' secondary metabolite gene clusters have been found, which code for the creation of extra, undiscovered chemicals.
Prenatal genetic screening systems are expected to increase rapidly in the near future. This is due to the fact that these programs assist pregnant moms in detecting genetic abnormalities in their children. Moreover, it is anticipated that in the next ten years, every newborn’s genome will be sequenced and stored in the electronic medical record. Emerging companies like Counsyl and Natera have released several genetic tests to get a competitive advantage in the industry, gauging the future market potential of genomics in newborn screening programs.
With the intention of sequencing 100, 000 human genomes, developing a genomic medicine service for the NHS, and facilitating new scientific discoveries, the UK government unveiled the 100, 000 Genomes Project in 2012. It has over £200 million in financing and will first concentrate on cancer and uncommon illnesses. Therefore, it is anticipated that these variables will provide new development opportunities for the local genomics market throughout the forecasted period.
The Germany market dominated the Europe Bioinformatics Market by Country in 2021; thereby, achieving a market value of $1.3 Billion by 2028. The UK market is anticipated to grow at a CAGR of 11.4% during (2022-2028). Additionally, The France market would showcase a CAGR of 13.1% during (2022-2028).
Based on Product & Services, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Sector, the market is segmented into Medical Biotechnology, Plant Biotechnology, Environmental Biotechnology, Animal Biotechnology, Forensic Biotechnology and Others. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, Proteomics and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Qiagen N.V., Agilent Technologies, Inc., Illumina, Inc., Waters Corporation, PerkinElmer Inc., Genedata AG, Neogenomics laboratories, BGI Group
Combining molecular and chemical methods, bioinformatics approaches are used in the search for natural compounds. The ability to conduct a large-scale screening and phylogenetic resolution are crucial molecular approach characteristics. Understanding the genetic and epigenetic elements of various bacterial taxa requires the use of comparative genome sequence analysis. The rising number of completely sequenced microbial genomes, such as those from well-known bacterial manufacturers of natural products, has made it obvious that these microbes have significantly greater genomic and metabolic capacities than once thought. This is because 'silent' or 'cryptic' secondary metabolite gene clusters have been found, which code for the creation of extra, undiscovered chemicals.
Prenatal genetic screening systems are expected to increase rapidly in the near future. This is due to the fact that these programs assist pregnant moms in detecting genetic abnormalities in their children. Moreover, it is anticipated that in the next ten years, every newborn’s genome will be sequenced and stored in the electronic medical record. Emerging companies like Counsyl and Natera have released several genetic tests to get a competitive advantage in the industry, gauging the future market potential of genomics in newborn screening programs.
With the intention of sequencing 100, 000 human genomes, developing a genomic medicine service for the NHS, and facilitating new scientific discoveries, the UK government unveiled the 100, 000 Genomes Project in 2012. It has over £200 million in financing and will first concentrate on cancer and uncommon illnesses. Therefore, it is anticipated that these variables will provide new development opportunities for the local genomics market throughout the forecasted period.
The Germany market dominated the Europe Bioinformatics Market by Country in 2021; thereby, achieving a market value of $1.3 Billion by 2028. The UK market is anticipated to grow at a CAGR of 11.4% during (2022-2028). Additionally, The France market would showcase a CAGR of 13.1% during (2022-2028).
Based on Product & Services, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Sector, the market is segmented into Medical Biotechnology, Plant Biotechnology, Environmental Biotechnology, Animal Biotechnology, Forensic Biotechnology and Others. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, Proteomics and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Qiagen N.V., Agilent Technologies, Inc., Illumina, Inc., Waters Corporation, PerkinElmer Inc., Genedata AG, Neogenomics laboratories, BGI Group
Scope of the Study
By Product & Services
- Knowledge Management Tools
- Bioinformatics Platforms
- Bioinformatics Services
By Sector
- Medical Biotechnology
- Plant Biotechnology
- Environmental Biotechnology
- Animal Biotechnology
- Forensic Biotechnology
- Others
By Application
- Genomics
- Chemoinformatics & Drug Design
- Transcriptomics
- Metabolomics
- Proteomics
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific SE
- Qiagen N.V.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Waters Corporation
- PerkinElmer Inc.
- Genedata AG
- Neogenomics laboratories
- BGI Group
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Bioinformatics Market, by Product & Services
1.4.2 Europe Bioinformatics Market, by Sector
1.4.3 Europe Bioinformatics Market, by Application
1.4.4 Europe Bioinformatics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Jun - 2022, Oct) Leading Players
Chapter 4. Europe Bioinformatics Market by Product & Services
4.1 Europe Knowledge Management Tools Market by Country
4.2 Europe Bioinformatics Platforms Market by Country
4.3 Europe Bioinformatics Services Market by Country
Chapter 5. Europe Bioinformatics Market by Sector
5.1 Europe Medical Biotechnology Market by Country
5.2 Europe Plant Biotechnology Market by Country
5.3 Europe Environmental Biotechnology Market by Country
5.4 Europe Animal Biotechnology Market by Country
5.5 Europe Forensic Biotechnology Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Bioinformatics Market by Application
6.1 Europe Genomics Market by Country
6.2 Europe Chemoinformatics & Drug Design Market by Country
6.3 Europe Transcriptomics Market by Country
6.4 Europe Metabolomics Market by Country
6.5 Europe Proteomics Market by Country
6.6 Europe Others Market by Country
Chapter 7. Europe Bioinformatics Market by Country
7.1 Germany Bioinformatics Market
7.1.1 Germany Bioinformatics Market by Product & Services
7.1.2 Germany Bioinformatics Market by Sector
7.1.3 Germany Bioinformatics Market by Application
7.2 UK Bioinformatics Market
7.2.1 UK Bioinformatics Market by Product & Services
7.2.2 UK Bioinformatics Market by Sector
7.2.3 UK Bioinformatics Market by Application
7.3 France Bioinformatics Market
7.3.1 France Bioinformatics Market by Product & Services
7.3.2 France Bioinformatics Market by Sector
7.3.3 France Bioinformatics Market by Application
7.4 Russia Bioinformatics Market
7.4.1 Russia Bioinformatics Market by Product & Services
7.4.2 Russia Bioinformatics Market by Sector
7.4.3 Russia Bioinformatics Market by Application
7.5 Spain Bioinformatics Market
7.5.1 Spain Bioinformatics Market by Product & Services
7.5.2 Spain Bioinformatics Market by Sector
7.5.3 Spain Bioinformatics Market by Application
7.6 Italy Bioinformatics Market
7.6.1 Italy Bioinformatics Market by Product & Services
7.6.2 Italy Bioinformatics Market by Sector
7.6.3 Italy Bioinformatics Market by Application
7.7 Rest of Europe Bioinformatics Market
7.7.1 Rest of Europe Bioinformatics Market by Product & Services
7.7.2 Rest of Europe Bioinformatics Market by Sector
7.7.3 Rest of Europe Bioinformatics Market by Application
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.2 Eurofins Scientific SE
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Recent strategies and developments:
8.2.4.1 Acquisition and Mergers:
8.3 Qiagen N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.4 Agilent Technologies, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Illumina, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.6 PerkinElmer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.7 Waters Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Neogenomics, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 BGI Group
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. Genedata AG
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific SE
- Qiagen N.V.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Waters Corporation
- PerkinElmer Inc.
- Genedata AG
- Neogenomics laboratories
- BGI Group
Methodology
LOADING...
